Knifsend Robin 4
4 · CytomX Therapeutics, Inc. · Filed Feb 21, 2020
Insider Transaction Report
Form 4
Knifsend Robin
Principal Accounting Officer
Transactions
- Award
Stock Option (right to buy)
2020-02-14+34,000→ 34,000 totalExercise: $7.13Exp: 2030-02-13→ Common Stock (34,000 underlying)
Footnotes (1)
- [F1]1/48th of the shares subject to the option vest on each monthly anniversary measured from January 1, 2020 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date, subject to the Reporting Person's continued service to the Issuer through each such date.